The prevention and treatment of sexually transmitted diseases in developing countries is complicated by a number of factors. High prevalence rates, inadequate diagnostic and treatment facilities, frequent resistance to less expensive antibiotics, associations both epidemiologically and clinically with the HIV pandemic, and a variety of social, behavioural and economic factors act as constraints to effective control.